The current profit and patent-driven drug development system steers research and development away from diseases that affect poor people. A recent resolution by the World Health Assembly is an important first step in establishing a needs-driven R&D agenda, writes the former Chair of MSF Sweden.

Development Today is a subscription-based journal published with 20 issues a year. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.

Print this article